// App-Quantinova.ai

: ACPA-POSITIVE RHEUMATOID ARTHRITIS PATIENTS BENEFITED MORE FROM ADVANCED TREATMENT STRATEGIES THAN ACPA-NEGATIVE RHEUMATOID ARTHRITISPATIENTS: 25-YEAR RESULTS OF A LONGITUDINAL COHORT STUDY

Researchers

Presenter

  • Xanthe Matthijssen

Principal Investigators

  • Ellis Niemantsverdriet

  • Thomas Huizinga

  • Annette van der Helm - van Mil

Medical Centers

  • Leiden University Medical Centre, Leiden, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Penicillamine

  • Methotrexate

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • The European Research Council (ERC) Under The European Union’s Horizon

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved